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Uranium occurs naturally in the earth’s
crust and surface and groundwaters. If the
bedrock consists mainly of uranium-rich
granitoids and granites and contains soft,
slightly alkaline bicarbonate waters, uranium
is highly soluble under oxidizing conditions
at a wide pH range. These conditions occur
widely in Finland (1), and consequently,
exceptionally high uranium concentrations
(up to 12,000 µg/L) are found in wells
drilled in bedrock (2,3).
Animal studies, as well as studies of
occupationally exposed persons, have shown
that the major health effect of uranium is
chemical kidney toxicity, rather than a radia-
tion hazard (4–7). Both functional and his-
tologic damage to the proximal tubulus has
been demonstrated (8–13). Little is known
about the effects of long-term environmental
uranium exposure in humans. Only two
small studies with 50–100 study persons
have been published on the kidney toxicity
of natural uranium from drinking water.
They have shown an association of uranium
exposure with increased urinary glucose,
alkaline phosphatase, and β-2-microglobulin
excretion (14), as well as increased urinary
albumin levels (15).
The World Health Organization (WHO)
(7) has proposed a guideline value of 2 µg/L
for uranium in drinking water, based on ani-
mal experiments in the absence of human
data. Risk assessment and establishment of
exposure limits for uranium in drinking water
is of considerable importance in areas with
granite rock, such as in Finland, where
approximately one-seventh of the population
uses drinking water with uranium concentra-
tion above 2 µg/L (16).
The aim of the present study was to eval-
uate possible kidney effects of chronic expo-
sure to uranium through drinking water.
Our sample size was larger than in earlier
studies, with a wide range of uranium con-
centration in drinking water and well-char-
acterized uranium exposure.
Materials and Methods
Study population. The source population
was based on the drinking water database of
STUK-Radiation and Nuclear Safety
Authority, with radioactivity measurements
of more than 5,000 drilled wells (Table 1).
The study was limited to 28 municipalities
in southern Finland, where uranium concen-
trations are highest and uranium measure-
ments have been made most extensively.
Sample-size calculations indicated that a
study population of 300 would provide ade-
quate statistical power (α = 0.05 one-sided,
1–β = 0.9) to detect a 20% increase in
β-2-microglobulin excretion and creatinine
clearance.
The ﬁrst questionnaire was mailed to 798
households, with questions about the use of
the drilled well, possible water purification
equipment, and medical history, as well as the
person’s willingness to participate in the study
(Table 1). Based on the ﬁrst questionnaire, we
selected 436 persons, restricted to those older
than 15 years of age, with a maximum of two
persons per household where a well had been
used for drinking water for at least 1 year.
The second questionnaire (Table 1) was
used to collect information on residential
history and use of well water, daily con-
sumption of water from the drilled well, and
liquids from other sources, as well as smok-
ing history, education, occupation, and use
of analgesics, other drugs, and herbal prod-
ucts. In addition, we obtained information
on kidney, cardiovascular, and liver diseases
and diabetes, as well as exposures to heavy
metals at work or during leisure time.
Seventy-eight percent of the persons who
received the second questionnaire consented
to participation in the study. The nonre-
spondents were slightly older (mean age 56
years vs. 48 years of respondents). Parental
consent was required for children younger
than 18 years of age. The study protocol was
approved by the National Public Health
Institute Standing Committee on Ethics
(project number 8/030399).
We restricted the study area to munici-
palities with at least one well in the original
high-uranium group. Persons with diabetes
mellitus (n = 4) or chronic use of methotrex-
ate (n = 1) or sodium aurothiomalate (n =
1), pregnant women (n = 4), and households
with effective equipment for removing ura-
nium from well water (n = 4) were excluded.
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Articles
Animal studies and small studies in humans have shown that uranium is nephrotoxic. However,
more information about its renal effects in humans following chronic exposure through drinking
water is required. We measured uranium concentrations in drinking water and urine in 325 per-
sons who had used drilled wells for drinking water. We measured urine and serum concentrations
of calcium, phosphate, glucose, albumin, creatinine, and β-2-microglobulin to evaluate possible
renal effects. The median uranium concentration in drinking water was 28 µg/L (interquartile
range 6–135, max. 1,920 µg/L) and in urine 13 ng/mmol creatinine (2–75), resulting in the
median daily uranium intake of 39 µg (7–224). Uranium concentration in urine was statistically
signiﬁcantly associated with increased fractional excretion of calcium and phosphate. Increase of
uranium in urine by 1 µg/mmol creatinine increased fractional excretion of calcium by 1.5% [95%
confidence interval (CI), 0.6–2.3], phosphate by 13% (1.4–25), and glucose excretion by 0.7
µmol/min (–0.4–1.8). Uranium concentrations in drinking water and daily intake of uranium were
statistically signiﬁcantly associated with calcium fractional excretion, but not with phosphate or
glucose excretion. Uranium exposure was not associated with creatinine clearance or urinary albu-
min, which reﬂect glomerular function. In conclusion, uranium exposure is weakly associated with
altered proximal tubulus function without a clear threshold, which suggests that even low uranium
concentrations in drinking water can cause nephrotoxic effects. Despite chronic intake of water
with high uranium concentration, we observed no effect on glomerular function. The clinical and
public health relevance of the ﬁndings are not easily established, but our results suggest that the
safe concentration of uranium in drinking water may be within the range of the proposed guideline
values of 2–30 µg/L. Key words: drinking water, glomerular function, renal tubular function, ura-
nium, uranium toxicity. Environ Health Perspect 110:337–342 (2002). [Online 1 March 2002]
http://ehpnet1.niehs.nih.gov/docs/2002/110p337-342kurttio/abstract.htmlThe final study population (Table 1) con-
sisted of 325 persons with 194 wells in 24
municipalities. The wells had been used as
the main source of drinking water for 13
years on average (range 1–34 years).
The mean age of the persons in the ﬁnal
study population was 52 years (range 15–82
years). Fifty percent of the persons were
women (n = 163). Fifty-six percent had never
smoked cigarettes, cigars, or pipes; 29% were
ex-smokers; and 15% were current smokers.
Thirty-eight persons reported exposure to
heavy metals, but the exposure periods had
been short; therefore, this exposure was con-
sidered insigniﬁcant.
Sample collection and preparation. The
water, urine, and nonfasting blood samples
were collected between 14 September and 1
December 1999. The samples were collected
at a time when the study persons had con-
sumed water from the drilled well during the
previous week. Samples were not taken
unless at least 1 week had elapsed since an
acute infection. The study persons collected
water samples for uranium analyses in a plas-
tic bottle in the evening. Overnight urine
samples were collected in plastic bottles and
the collection times recorded (median 11 hr,
range 7–17 hr).
The study persons brought the samples
to the laboratory in the morning, and we
measured urine volume (median 800 mL,
range 210–2,600 mL). The urine samples
for calcium and phosphate analyses were
conserved with hydrochloric acid. During
the same visit, we collected a spot urine
sample for analyses of β-2-microglobulin
(conserved with sodium bicarbonate) and
drew blood samples to obtain serum for
clinical chemistry. In addition, we measured
supine blood pressure, body weight, and
height according to standard procedures.
The water and overnight urine samples for
uranium analyses were conserved with nitric
acid. Water, serum, and overnight and spot
urine samples were stored frozen at –20°C
until analysis.
Uranium exposure assessment. Uranium
in drinking water and urine were analyzed
blind with inductively coupled plasma mass
spectrometry (ICP-MS) in the laboratory of
Consulting Engineers Paavo Ristola
Laboratory, Hollola, Finland (Table 2).
Urine samples were diluted 1:5 with 2%
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Table 1. Selection of the study population.
Original uranium  Number of persons  Number of persons to  Number of persons  Final study
concentration  who replied to the  whom the second who attended   population after
groupa ﬁrst questionnaire  questionnaire was sent  the study  exclusions
Low (< 10 µg/L) 398 150 113 108
Medium (10–100 µg/L) 363 150 121 116
High (> 100 µg/L) 347 136 105 101
Total 1,108 436 339 325
aTo obtain a wide range of exposure levels, the wells were divided primarily into three groups based on the uranium concentrations calculated from gross alpha analyses (33) (low, n =
300; medium, n = 300; and high, n = 198).
Table 2. Analytical methods used in the study.
Analysis Method Detection limit
Uranium in water  ICP-MS (Elan 6000; Perkin Elmer, Bodenseewerk, GmbH, Toronto, Canada)  0.0004 µg/L
Uranium in urine 0.002 µg/L
Serum creatinine  Jaffe method (Konelab 60i analyzer and reagents; Konelab Co., Espoo, Finland)  19 µmol/L
Urine creatinine Clinical Chemistry automatic analyzer (Konelab Co.) 0.4 mmol/L
Serum calcium Colored complex with Arsenazo III (Konelab 60i analyzer and reagents; Konelab Co.)  0.5 mmol/L
Urine calcium Atomic absorption spectrophotometry (EFOX 5053; Eppendorf, Hamburg, Germany) 0.1 mmol/L
Serum phosphate  Colored complex with ammonium molybdate (Konelab 60i analyzer; Konelab Co.)  0.1 mmol/L
Urine phosphate 2.0 mmol/L
Serum albumin Bromocresol purple method (Konelab 60i analyzer; Konelab Co.)  5 g/L
Urine albumin Immunological method (Beckman Immunochemistry Systems Micro Albumin; Beckman Instruments Inc.,  2 mg/L
Galway, Ireland) using a Beckman Array Protein analyzer (Beckman Instruments Inc., San Diego, CA, USA)
Serum glucose Hexokinase method (Konelab 60i analyzer; Konelab Co.)  0.5 mmol/L
Urine glucose 1 mmol/L
Serum β-2-microglobulin Immunoturbidimetric method (Tina-quant β-2-microglobulin; Roche Diagnostics GmbH, Mannheim, Germany)  0.2 mg/L
Urine β-2-microglobulin with a Hitachi model 717 automatic analyzer (Hitachi Ltd., Tokyo, Japan) 0.1 mg/L
Figure 1. Correlations of the uranium concentration in drinking water and in urine [log(y) = 0.01 + 0.80
log(x); Pearson correlation = 0.85].
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Uranium in drinking water (µg/L)HNO3 before analyses. Water samples were
diluted with 2% HNO3 if uranium in water
exceeded 500 µg/L.
For quality assurance, split water (n = 38)
and urine samples (n = 20) were analyzed.
The coefﬁcient of variation for water samples
was 3.0% (regression coefﬁcient = 0.98) and
for urine samples 16% (regression coefﬁcient
= 0.99). In addition, 15 water samples were
analyzed blind by ICP–MS in another labora-
tory (Nuclear Research Center, Negev, Beer-
Sheva, Israel, by Zeev Karpas); these samples
were also analyzed for uranium isotopes 238U
and 234U by radiochemical and alpha-spectro-
metric methods (2) at STUK–Radiation and
Nuclear Safety Authority. The results in dif-
ferent laboratories were comparable between
the ICP–MS measurements (regression coef-
ficient = 0.91) and between the ICP–MS
and the radiochemical analyses (regression
coefﬁcient = 0.96).
We used four measures of uranium expo-
sure: uranium concentration in drinking
water (micrograms per liter), uranium con-
centration in urine (nanograms per liter or
nanograms per millimole creatinine), daily
intake of uranium from drinking water
(volume used × concentration, micrograms),
and cumulative intake from drinking water
(daily intake × duration of the water con-
sumption, milligrams). The exposure vari-
ables were highly correlated with each other
(R2 from 0.54 to 0.92) (Figure 1). Only the
uranium concentrations in drinking water
and in urine (per creatinine) and daily intake
related to the outcome variables are shown.
The exposure variables were analyzed both as
continuous and categoric variables. We chose
the cut points of the uranium concentration
in drinking water based on the present or
suggested guideline values for drinking water,
and the cut points for uranium in urine and
daily intake were approximate quintiles.
Kidney function assessment. We selected
excretion of glucose, calcium, phosphate,
and β-2-microglobulin as indicators of
effects on proximal tubulus, and creatinine
clearance and urinary albumin as indicators
for glomerular function. These outcome
measures were chosen based on previous
results on uranium toxicity and suitability for
kidney function monitoring in a large study
population. Because the fractional excretion
(formula shown in Table 3 footnote) is
independent of the urinary volume or collec-
tion time (eliminating one source of uncer-
tainty), we used fractional excretion of
calcium and phosphate as the main outcome
measure in the final analyses. Urinary glu-
cose and albumin were used as clinically rele-
vant measures of kidney dysfunction. The
kidney function parameters were measured
at the Department of Clinical Chemistry of
Kuopio University Hospital according to
certiﬁed laboratory procedures (Table 2).
Because 65% of β-2-microglobulin con-
centrations in urine were below the detec-
tion limit of the assay, we analyzed the
variable as a trichotomous variable.
Statistical analyses. For the all parame-
ters determined, the observations below the
detection limits were recorded as half of the
detection limit.
The crude and adjusted (by age, sex, and
body mass index) analyses were performed
using generalized linear models assuming
normal distribution of the outcome and an
identity link function (y = a + bx; a = base-
line, b = regression coefficient, y = kidney
function, x = uranium exposure) in SAS ver-
sion 6.12 PROC GENMOD (SAS Institute
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Table 3. Uranium exposure from drinking water and measured kidney function parameters among the study population (n = 325).
Percentile
Parameter Mean Median 25th 75th Range
Uranium in drinking water (µg/L) 131 28 6.2 135 0.001–1,920
Uranium in urine (µg/L) 424 78 17 413 1–5,650
Uranium in urine (ng/mmol creatinine) 73 13 2.5 75 0.1–955
Daily intake of uranium from drinking water (µg) 235 39 7.5 224 0.0006–4,128
Daily intake of uranium from drinking water (µg/kg body weight) 3.2 0.6 0.1 3.2 0.000007–52
Cumulative intake of uranium from drinking water (mg) 1,360 129 24 887 0.001–33,100
Intake of drilled-well water (L/day)a 1.7 1.6 1.2 2.0 0.3–5.6
Total ﬂuid intake (L/day)a 2.7 2.6 2.1 3.2 1.0–6.7
Duration of the use of drilled well (years) 13 11 6 20 1.3–34
Calcium fractional excretion (%)b 1.6 1.3 0.8 2.0 0.08–10
Phosphate fractional excretion (%)c 27 24 19 33 3.6–177
Glucose excretion (µmol/min)d 0.9 0.7 0.5 0.9 0.1–21
Creatinine clearance (mL/min)e 103 100 83 116 20–239
Urinary albumin (µg/min)f 3.3 1.7 1.1 2.6 0.3–92
β-2-Microglobulin concentration in urine (mg/L) 0.12 0.05 0.05 0.13 0.05–6.0
aFrom a questionnaire covering ﬂuid intake (from drinks and soups) at home and elsewhere. b(Urine calcium × serum creatinine)/(serum calcium × urine creatinine) × 100. c(Urine phos-
phate × serum creatinine)/(serum phosphate × urine creatinine) × 100. d(Urine glucose × urine volume)/urine collection time. e[(Urine creatinine × urine volume)/serum creatinine] 
÷ urine collection time × (1.73/body surface). f(Urine albumin × urine volume)/urine collection time.
Table 4. Association of uranium exposure in kidney function indicators, blood pressure, and diuresis.
Uranium in urine  Uranium in drinking  Daily intake of uranium
(µg/mmol creatinine) water (mg/L) (mg)
b (95%CI) b (95%CI) b (95%CI)
Calcium fractional excretion (%)  1.5 (0.6–2.3) 0.5 (0.06–1.0) 0.4 (0.2–0.7)
Phosphate fractional excretion (%)  13 (1.4–25) 4.5 (–2.3–11) 3.1 (–0.5–6.7)
Glucose excretion (µmol/min)  0.7 (–0.4–1.8) 0.2 (–0.4–0.8) 0.2 (–0.1–0.5)
Creatinine clearance (mL/min)  –7.6 (–33–18) 1.7 (–13–16) 0.8 (–6.8–8.4)
Urinary albumin (µg/min)  –2.1 (–8.8–4.6) 0.1 (–3.7–3.9 ) 0.2 (–1.8–2.2)
β-2-Microglobulin in urine 
(< 0.1; 0.1–0.39; ≥ 4 ng/L) –107 (–523–309) –82 (–318–153) –49 (–175–76)
Systolic blood pressure (mmHg)a 6.8 (–5.7–19) 7.4 (0.3–14) 4.1 (0.3–7.9)
Diastolic blood pressure (mmHg)a 8.5 (1.4–15) 5.0 (0.9–9.0) 3.0 (0.8–5.1)
Diuresis (µL/min)a 599 (129–1,070) 61 (–211–332) 71 (–73–217)
Values shown are the increase of outcome variables (b), which is associated with an increase of exposure variables by one unit, and 95% CI (n = 325). Uranium exposure is a continuous
variable adjusted for age, sex, and body mass index, except where indicated.
aAdjusted for age, sex, body mass index, and smoking.Inc., Cary, NC, USA). An adjustment for
duration of uranium exposure, education,
occupation, use of analgesics, or smoking
(never, ex-smoker, or current smoker) did
not change the effect of uranium exposure to
kidney functions and were therefore not used
as covariates. The results of univariate analy-
ses were similar to those from multivariate
analyses, and only adjusted results are shown.
We also conducted an analysis using a
log transformation, but the results remained
essentially unchanged. There was no obvious
skewness for residuals across predicted values
for any of the main outcome measures (i.e.,
showing no substantial departure from nor-
mality). No systematic variation in residuals
was observed in relation to exposure vari-
ables, suggesting that the effect of uranium
was adequately described by a linear expo-
sure term. To estimate the shape of the
dose–response curve, we also conducted
analyses separately for those above and below
median exposure. These analyses were con-
ducted for calcium and phosphate fractional
excretions as end points.
Results
The uranium concentration in water varied
from 0.001 to 1,920 µg/L, and 30% of the
concentrations exceeded 100 µg/L. The
median daily intake of uranium from drink-
ing water was 39 µg (Table 3).
An increase in the daily intake of ura-
nium from drinking water by 1 µg was asso-
ciated with an increase of 0.21 ng of
uranium in urine/mmol creatinine (95%
conﬁdence interval (CI), 0.19–0.24) (Figure
1). The median of the ratio of uranium in
urine (micrograms per liter)/uranium in
water (micrograms per liter) was 3 × 10–4
(25th and 75th percentiles 2 × 10–4 and 7 ×
10–4). The ratio was not associated with the
exposure levels (daily intake, p = 0.6), age (p
= 0.5), or sex (p = 0.3).
Uranium exposure (uranium in urine,
uranium in drinking water, and uranium
intake) was statistically significantly associ-
ated with increased fractional excretion of
calcium (p = 0.0006, 0.03, and 0.001 for
continuous exposure variables, respectively)
(Table 4; Figure 2). Phosphate fractional
excretion was statistically significantly (p =
0.03) associated with uranium concentration
in urine, but not with uranium in drinking
water (p = 0.2) or uranium intake (p = 0.09)
(Table 4). The tendency of uranium expo-
sure to increase glucose excretion was not
statistically significant. An increase of ura-
nium in urine by 1 µg/mmol creatinine was
associated with an increase of fractional
excretion of calcium by 1.5% (95% CI,
0.6–2.3), phosphate by 13% (1.4–25), 
and glucose excretion by 0.7 µmol/min
(–0.4–1.8) (Table 4). We observed a statisti-
cally significant increase in phosphate frac-
tional excretion for drinking water uranium
concentration > 300 µg/L relative to < 2
µg/L (Table 5). Similarly, the study persons
with the highest uranium excretion and
intake had elevated calcium and phosphate
fractional excretion compared with the low-
est exposure groups (Tables 6 and 7). We
observed no association between uranium
exposure and creatinine clearance, urinary
albumin, or concentration of β-2-microglob-
ulin in urine (Table 4).
Uranium exposure was associated with
increased systolic and diastolic blood pressures
and diuresis (urine volume/time) when contin-
uous exposure variables were used (Table 4),
but the association was statistically signiﬁcant
only between diuresis and the highest categoric
exposure group (uranium in urine) compared
with the lowest exposure group (Table 7).
In dose–response analyses, risk estimates
tended to be slightly higher for the subgroup
with uranium levels below the median than
for those above the median, whether calcium
or phosphate fractional excretion was used as
the end point and for both water and urinary
uranium concentrations. A squared uranium
exposure term was not statistically signiﬁcant
and had a negative regression coefﬁcient.
Discussion
The study showed an association between
increased uranium exposure through drink-
ing water and tubular function, but not
between uranium exposure and indicators of
glomerular injury (i.e., creatinine clearance
and urinary albumin). Even though the
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Figure 2. Uranium concentration in urine and fractional excretion of calcium crude values. The line repre-
sents the smoothed running means.
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Table 5. Kidney function indicators for uranium in water.
Uranium in water (µg/L) 0.001–1.9 2–9 10–19 20–99 100–299 300–1,920
n 37 82 25 83 55 43
Calcium fractional excretion (%) 
Mean 1.5 1.3 1.4 1.5 1.8 2.0
b Ref –0.19 (–0.61–0.23) –0.11 (–0.67–0.46) –0.04 (–0.46–0.38) 0.23 (–0.22–0.69) 0.38 (–0.10–0.87)
Phosphate fractional excretion (%) 
Mean 23 27 28 26 28 32
b Ref 4.6 (–1.2–10) 5.5 (–2.3–13) 2.9 (–2.9–8.7) 5.1 (–1.2–11) 9.0 (2.4–16)
Glucose excretion (µmol/min) 
Mean 0.8 0.7 0.8 1.0 0.8 1.0
b Ref 0.01 (–0.51–0.53) 0.05 (–0.65–0.74) 0.23 (–0.28–0.75) 0.09 (–0.47–0.64) 0.29 (–0.30–0.89)
Values shown are the increase of outcome variables (b) compared with the lowest exposure strata (Ref), 95% CI, and means of unadjusted outcome variables in each exposure strata (n
= 325). Uranium exposure is a categorized variable adjusted for age, sex, and body mass index.effects were of modest magnitude, they
occurred without a clear threshold.
The results are consistent with previous
ﬁndings, suggesting that uranium in drink-
ing water affects kidney tubular function
(14,15). In our study, uranium concentra-
tions were higher than in the earlier studies.
In the study by Zamora et al. (14) of persons
using water containing < 1 µg/L uranium (n
= 20) or between 2 and 780 µg/L (n = 30),
the daily intake of uranium was 0.3–570 µg.
Increased urinary glucose, β-2-microglobu-
lin, and alkaline phosphatase were associated
with daily uranium intake, but most values
remained within the normal range. Indicators
for glomerular injury (urinary creatinine and
total protein) were not associated with ura-
nium intake. In another study, the uranium
concentrations in water were between < 0.1
and 50 µg/L (n = 100), and slightly increased
levels of urinary albumin were associated
with cumulative intake of uranium from
drinking water (15). Other biochemical para-
meters in urine were not evaluated.
We did not ﬁnd an association between
uranium exposure and excretion of β-2-
microglobulin in urine. The results are 
consistent with the previous studies (14,15)
in that β-2-microglobulin and albumin
rarely exceeded the normal range.
Our findings are supported by experi-
mental findings on toxicity of uranium in
laboratory animals. Very high doses of ura-
nium (10–25 mg/kg body weight) cause an
acute renal failure (8,9,17,18), and lower
exposure levels induce morphologic and
functional changes in kidneys (10,12,19).
The primary target is the proximal convo-
luted tubule, and the damage at higher doses
is irreversible (8–10). Histologic changes are
paralleled by glucosuria, aminoaciduria, pro-
teinuria, polyuria, and increased excretion of
enzymes such as alkaline phosphatase and
lactate dehydrogenase (5,10,12,17,20,21) as
indicators of altered function of proximal
tubules and cell damage, respectively.
In this study, the changes in tubular
function were associated more closely with
urinary uranium concentration than daily
intake or uranium concentration in water.
Uranium concentration in groundwater may
vary over time, and therefore a spot sampling
does not necessarily represent long-term ura-
nium exposure. Additionally, self-reported
estimates of drinking water consumption
were required for calculating the daily
intake, which adds uncertainty. Urinary
uranium concentration is independent of
these sources of uncertainty. Furthermore, it
also encompasses individual variation in ura-
nium kinetics within the body, which fur-
ther increases its validity as an indicator of
uranium concentration in the kidney.
Renal effects of uranium were not associ-
ated with the duration of well-water use or
with cumulative uranium intake. These ﬁnd-
ings suggest that short-term exposure is most
relevant for kidney effects of uranium, and
effects are not likely to be cumulative. This
is also supported by kinetic studies (4–6).
In our study population, drinking water
is the predominant source of uranium, espe-
cially among those with elevated uranium
concentrations in well water. We had no
data on dietary intake of uranium, but the
average daily intake of uranium in food in
other countries has been reported to be 1–2
µg/day (22,23). We had no information on
uranium in previous drinking water sources.
However, the ﬁndings were independent of
duration of residence in the dwelling, sug-
gesting that this is not likely to affect the
results. We analyzed only uranium from the
water samples. To confound the results,
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Table 6. Kidney function indicators for daily intake of uranium.
Daily intake of U (µg) 0.0006–4.9 5–19 20–99 100–299 300–4,128
n 60 68 81 51 65
Calcium fractional excretion (%) 
Mean 1.4 1.3 1.4 1.8 1.9
b Ref –0.08 (–0.46–0.30) –0.05 (–0.41–0.31) 0.37 (–0.03–0.78) 0.45 (0.07–0.83)
Phosphate fractional excretion (%) 
Mean 25 26 26 28 31
b Ref 2.0 (–3.3–7.2) 0.93 (–4.1–6.0) 2.8 (–2.9–8.5) 5.9 (0.56–11.2)
Glucose excretion (µmol/min) 
Mean 0.7 0.7 0.8 1.2 1.0
b Ref 0.02 (–0.45–0.48) 0.02 (–0.42–0.46) 0.51 (–0.01–1.01) 0.23 (–0.24–0.70)
Values shown are the increase of outcome variables (b) compared with the lowest exposure strata (Ref), 95% CI, and means of unadjusted outcome variables in each exposure strata
(n = 325). Uranium exposure is a categorized variable adjusted for age, sex, and body mass index. 
Table 7. Kidney function indicators, blood pressure, and diuresis for uranium in urine.
U in urine (ng/mmol creatinine) 0.1–1.9 2–9 10–19 20–99 100–955
n 68 80 37 72 68
Calcium fractional excretion (%) 
Mean 1.3 1.4 1.7 1.5 2.0
b Ref 0.05 (–0.30–0.40) 0.28 (–0.15–0.71) 0.09 (–0.27–0.45) 0.66 (0.29–1.0)
Phosphate fractional excretion (%) 
Mean 25 26 26 26 31
b Ref 2.7 (–2.2–7.7) 1.9 (–4.2–7.9) 2.9 (–2.1–8.0) 7.7 (2.6–13)
Glucose excretion (µmol/min) 
Mean 0.7 0.7 1.2 0.8 1.0
b Ref 0.01 (–0.42–0.44) 0.52 (–0.02–1.05) 0.07 (–0.37–0.52) 0.30 (–0.16–0.75)
Systolic blood pressure (mmHg)
Mean 135 134 138 139 139
ba Ref –1.2 (–6.5–4.0) 0.3 (–6.1–6.7) 3.0 (–2.4–8.3) 1.4 (–4.1–6.9)
Diastolic blood pressure (mmHg)
Mean 82 81 82 83 85
ba Ref –1.3 (–4.3–1.6) –0.4 (–4.0–3.2) 1.1 (–1.9–4.1) 2.1 (–1.0–5.2)
Diuresis (mL/min) 
Mean 1.2 1.3 1.2 1.3 1.6
ba Ref 0.12 (–0.07–0.32) 0.05 (–0.18–0.29) 0.11 (–0.09–0.31) 0.38 (0.18–0.58)
Values shown are the increase of outcome variables (b) compared with the lowest exposure strata (Ref), 95% CI, and means of unadjusted outcome variables in each exposure strata
(n = 325). Uranium exposure is a categorized variable adjusted for age, sex, and body mass index, except where indicated.
aAdjusted for age, sex, body mass index, and smoking. other chemicals in drinking water should be
associated with both uranium concentration
and outcome measures. In another study we
measured heavy metals, some of which are
known nephrotoxic agents, in Finnish
drilled wells. These preliminary results show
that heavy metals other than uranium occur
extremely rarely in substantial concentra-
tions. Furthermore, none of the heavy met-
als are positively correlated with uranium.
Therefore, other chemicals in drinking water
are not likely to confound the results.
The clinical signiﬁcance of the results is
not easily established. We found an association
between uranium exposure and tubular func-
tion (calciuria, phosphaturia, and polyuria),
but no changes in glomerular function (creati-
nine clearance, albuminuria). Tubular dys-
function manifested within the normal
physiologic range, but occurred without an
apparent threshold. Excretion of calcium,
phosphate, and glucose remained within nor-
mal range in most subjects, even for persons
with very high and long-lasting exposure to
uranium. These ﬁndings are consistent with
studies of occupational exposure to uranium
failing to demonstrate overt kidney disease
among workers exposed to uranium (24–26).
However, most occupational studies have not
used sufﬁciently sensitive functional indicators
to detect latent kidney dysfunction, and thus
minor effects may have remained unobserved.
Tubular dysfunction may merely repre-
sent a manifestation of subclinical toxicity,
and it is unclear if it carries a risk of develop-
ment into kidney failure or overt illness.
However, alterations in renal functions
induced by uranium cannot be ignored,
although their health signiﬁcance remains to
be established. They may decrease the spare
capacity of kidney function or promote clin-
ical manifestation of other harmful insults.
The changes in kidney function, even in the
absence of renal failure, may have subtle
indirect health consequences. Increased cal-
cium leaking into urine may lead to negative
calcium balance and increase susceptibility
to osteoporosis. An association between
blood pressure and urinary uranium excre-
tion may be of clinical importance to sub-
jects with a predisposition to hypertension.
Uranium elevates serum renin concentration
(17,27), which may explain our finding.
These ﬁndings deserve further exploration.
There is no evidence that natural ura-
nium in drinking water would cause cancer,
and chemical toxicity of natural uranium is
likely to be much more important for
human health than risk of cancer from radia-
tion (4,6,28). The median annual effective
dose based on the uranium intake and the
average uranium isotope ratios in drilled-well
waters (2) and dose conversion factors (29)
was 0.02 mSv/year (maximum 2 mSv/year),
and hence remains lower than the worldwide
average dose from natural sources (2.4
mSv/year) (30).
Guideline values for drinking water rang-
ing from 2 µg/L (7) to 100 µg/L (31) have
been proposed. The values are based on ani-
mal studies, with application of a safety factor
to take into account the lack of human stud-
ies. Based on this report and two previous
reports (14,15), the results from human stud-
ies could be used for setting guidelines. We
found altered tubular function statistically sig-
nificant at water uranium concentrations
exceeding 300 µg/L. However, heterogeneity
of exposure and of health effect (i.e., suscepti-
bility) are possible, and this should be consid-
ered in setting the guideline values. Because
our study and other human studies have
shown an effect of uranium on kidney func-
tion, guideline values based on these studies
are unlikely to be substantially higher than
those suggested previously. Due to the lack of
an obvious threshold for the nephrotoxic effect
and possible heterogeneity of effect within
populations, a guideline value of 100 µg/L
seems too high, whereas values in the range
proposed by the WHO (2 µg/L) (7) and the
U.S. Environmental Protection Agency (U.S.
EPA) (30 µg/L) (32) appear appropriate.
In summary, we found an association
between increased uranium exposure through
drinking water and excretion of several
solutes in urine. The effect is consistent with
reduced reabsorption in kidney tubules. The
public health implications of these findings
remain uncertain, but suggest that the safe
concentration of uranium in drinking water
may be close to the guideline values proposed
by the WHO and the U.S. EPA.
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